Walzl G - Search Results

1

Distinct serum biosignatures are associated with different tuberculosis treatment outcomes.

Ronacher K, Chegou NN, Kleynhans L, Djoba Siawaya JF, du Plessis N, Loxton AG, Maasdorp E, Tromp G, Kidd M, Stanley K, Kriel M, Menezes A, Gutschmidt A, van der Spuy GD, Warren RM, Dietze R, Okwera A, Thiel B, Belisle JT, Cliff JM, Boom WH, Johnson JL, van Helden PD, Dockrell HM, Walzl G. Ronacher K, et al. Among authors: walzl g. Tuberculosis (Edinb). 2019 Sep;118:101859. doi: 10.1016/j.tube.2019.101859. Epub 2019 Aug 12. Tuberculosis (Edinb). 2019. PMID: 31434026 Free PMC article.

2

TB: a partnership for the benefit of research and community.

Walzl G, Beyers N, van Helden P. Walzl G, et al. Trans R Soc Trop Med Hyg. 2005 Oct;99 Suppl 1:S15-9. doi: 10.1016/j.trstmh.2005.06.006. Trans R Soc Trop Med Hyg. 2005. PMID: 16085174

3

Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment responders.

Veenstra H, Baumann R, Carroll NM, Lukey PT, Kidd M, Beyers N, Bolliger CT, van Helden PD, Walzl G. Veenstra H, et al. Among authors: walzl g. Clin Exp Immunol. 2006 Aug;145(2):252-60. doi: 10.1111/j.1365-2249.2006.03144.x. Clin Exp Immunol. 2006. PMID: 16879244 Free PMC article.

4

Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapy.

Brahmbhatt S, Black GF, Carroll NM, Beyers N, Salker F, Kidd M, Lukey PT, Duncan K, van Helden P, Walzl G. Brahmbhatt S, et al. Among authors: walzl g. Clin Exp Immunol. 2006 Nov;146(2):243-52. doi: 10.1111/j.1365-2249.2006.03211.x. Clin Exp Immunol. 2006. PMID: 17034576 Free PMC article.

5

Antimicrobial resistance in tuberculosis: an international perspective.

van Helden PD, Donald PR, Victor TC, Schaaf HS, Hoal EG, Walzl G, Warren RM. van Helden PD, et al. Among authors: walzl g. Expert Rev Anti Infect Ther. 2006 Oct;4(5):759-66. doi: 10.1586/14787210.4.5.759. Expert Rev Anti Infect Ther. 2006. PMID: 17140353 Review.

6

TB epidemiology and human genetics.

van Helden PD, Möller M, Babb C, Warren R, Walzl G, Uys P, Hoal E. van Helden PD, et al. Among authors: walzl g. Novartis Found Symp. 2006;279:17-31; discussion 31-41, 216-9. Novartis Found Symp. 2006. PMID: 17278383 Review.

7

Correlates for disease progression and prognosis during concurrent HIV/TB infection.

Djoba Siawaya JF, Ruhwald M, Eugen-Olsen J, Walzl G. Djoba Siawaya JF, et al. Among authors: walzl g. Int J Infect Dis. 2007 Jul;11(4):289-99. doi: 10.1016/j.ijid.2007.02.001. Epub 2007 Apr 18. Int J Infect Dis. 2007. PMID: 17446108 Free article. Review.

8

Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients.

Babb C, van der Merwe L, Beyers N, Pheiffer C, Walzl G, Duncan K, van Helden P, Hoal EG. Babb C, et al. Among authors: walzl g. Tuberculosis (Edinb). 2007 Jul;87(4):295-302. doi: 10.1016/j.tube.2007.03.001. Epub 2007 Apr 20. Tuberculosis (Edinb). 2007. PMID: 17449323

9

Changes in the kinetics of intracellular IFN-gamma production in TB patients during treatment.

Veenstra H, Crous I, Brahmbhatt S, Lukey P, Beyers N, van Helden PD, Walzl G. Veenstra H, et al. Among authors: walzl g. Clin Immunol. 2007 Sep;124(3):336-44. doi: 10.1016/j.clim.2007.05.014. Epub 2007 Jul 5. Clin Immunol. 2007. PMID: 17616440

10

High levels of intracellular IL-4 are expressed in circulating apoptotic T cells in patients with tuberculosis and in community controls.

Veenstra H, Baumann R, Lukey PT, Beyers N, van Helden PD, Walzl G. Veenstra H, et al. Among authors: walzl g. Tuberculosis (Edinb). 2008 Jan;88(1):21-30. doi: 10.1016/j.tube.2007.09.001. Epub 2007 Oct 30. Tuberculosis (Edinb). 2008. PMID: 17977794

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

291 results

Search Page